Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-27

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Collagenase Clostridium Histolyticum

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    John with Endo on Dupuytren's Contracture Treatment with XIAFLEX®
    John with Endo on Dupuytren's Contracture Treatment with XIAFLEX®

    20 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/john-elway-teams-up-with-endo-to-share-update-on-dupuytrens-contracture-and-treatment-with-xiaflex-collagenase-clostridium-histolyticum-302310665.html

    PR NEWSWIRE
    20 Nov 2024
    Share Share
    Auxilium`s Biologic Xiaflex (Clostridium) Receives Suppl. Approval in US
    Auxilium`s Biologic Xiaflex (Clostridium) Receives Suppl. Approval in US

    11 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125338

    FDA
    11 Oct 2024
    Share Share
    Endo Announces Publication of XIAFLEX Data Analysis in Peer-Reviewed Urology®
    Endo Announces Publication of XIAFLEX Data Analysis in Peer-Reviewed Urology®

    05 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endo-announces-publication-of-xiaflex-collagenase-clostridium-histolyticum-data-analysis-in-peer-reviewed-urology-301841484.html

    PR NEWSWIRE
    05 Jun 2023
    Share Share
    Endo to Cease Production and Sale of Qwo
    Endo to Cease Production and Sale of Qwo

    06 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/endo-to-cease-production-and-sale-of-qwo-collagenase-clostridium-histolyticum-aaes-301696374.html

    PRNEWSWIRE
    06 Dec 2022
    Share Share
    Auxilium' Biologic Xiaflex (Collagenase Clostridium Histolyticum) Receives Approval in the U.S.
    Auxilium' Biologic Xiaflex (Collagenase Clostridium Histolyticum) Receives Approval in the U.S.

    02 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125338

    FDA
    02 Nov 2022
    Share Share
    Endo plays it straight with new Peyronie's disease tool
    Endo plays it straight with new Peyronie's disease tool

    28 Oct 2022

    // Ben Adams FIERCEPHARMA

    https://www.fiercepharma.com/marketing/endo-plays-it-straight-new-peyronies-disease-smartphone-self-awareness-tool

    Ben Adams FIERCEPHARMA
    28 Oct 2022
    Share Share